By focusing on the protein kinase B/glycogen synthase kinase-3β/β-catenin signaling pathway, which is involved in HCC cellular motility and invasiveness, SIRT2 overexpression stimulates EMT and motility of HCC cells (Figure 5 B, H)188. This evidence concerns the gene SIRT2 and hepatocellular carcinoma.